drugset / Trial / NCT02765867

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

NCT02765867

Phase 1 Completed 18 enrolled Indivior Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic profile of an injection of RBP-6000.

Timeline

Start
2010-11
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Subcutaneous